Comparison of aroma massage therapy in cancer patients

Not Applicable

• Conditions: neoplasms.; Malignant neoplasms; C00, C01,

• Registration Number: IRCT2015102824757N1
• Lead Sponsor: Yasuj University of Medical sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 75

Inclusion Criteria

inclusion criteria: who had been received chemotherapy include Oxaliplatine or Cisplatine; have experienced at least minimum symptoms of neuropathic pain and nausea and vomiting and pain and fatigue; filled in patient's consent; aged above 16 years; Platelet above 50000; WBC more than 2500; positive olfactory test; negative sensitivity test and Exclusion criteria are: disorientation to time and place and person; known mental disorder; DVT; coagulation disorder; skin problem; bone fraction and extensive bruise

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ausea and vomiting. Timepoint: 1hour before,24 hours and 2 days after intervention. Method of measurement: MASCC Anti Emetic Tool.;Fatigue. Timepoint: 1 hour before each intervention, 24 hour and 48 hour after each intervention. Method of measurement: Schwart's Fatigue Scale.;Pain. Timepoint: 1 hour before each intervention, 24 hour and 48 hour after each intervention. Method of measurement: Brief Pain Inventory.;Neuropathy. Timepoint: 1 hour before and 7 days after each intervention. Method of measurement: FACT-GOG questionnaire for neuropathy.